Literature DB >> 20054273

Venous thromboembolism risk and prophylaxis in the acute care hospital setting (ENDORSE survey): findings in surgical patients.

Ajay K Kakkar1, Alexander T Cohen, Victor F Tapson, Jean-Francois Bergmann, Samuel Z Goldhaber, Bruno Deslandes, Wei Huang, Frederick A Anderson.   

Abstract

OBJECTIVE: To evaluate venous thromboembolism (VTE) risk in patients who underwent a major operation, including the use of, and factors influencing, American College of Chest Physicians-recommended types of VTE prophylaxis. SUMMARY BACKGROUND DATA: The Epidemiologic International Day for the Evaluation of Patients at Risk for Venous Thromboembolism in the Acute Hospital Care Setting (ENDORSE) survey, conducted in 358 hospitals in 32 countries, reported that globally, more than 40% of at-risk patients do not receive VTE prophylaxis. Limited data are available regarding VTE prophylaxis practices according to surgery type and patient characteristics.
METHODS: Patients aged >or=18 years undergoing major surgery were included in this prespecified subanalysis. VTE risk and use of prophylaxis were determined from hospital medical records according to the 2004 American College of Chest Physicians guidelines. Multivariable analyses were performed to identify factors associated with VTE prophylaxis use.
RESULTS: Of the 18,461 patients in ENDORSE who had undergone major surgery, 17,084 (92.5%) were at-risk for VTE and 10,638 (62.3%) received prophylaxis. Use of prophylaxis varied according to major surgery type from 86.0% for orthopedic surgery to 53.8% in urologic/gynecologic and 53.6% in other procedures. Major orthopedic surgery was most strongly associated with prophylaxis use (hip replacement: odds ratio 6.2, 95% confidence interval [CI] 5.0-7.6; knee replacement: odds ratio 5.9, 95% CI 4.6-7.8).
CONCLUSIONS: The majority of surgical patients are at high-risk for VTE. Despite long-standing recognition of the high-risk for VTE in surgical patients, thromboprophylaxis remains underutilized.

Entities:  

Mesh:

Year:  2010        PMID: 20054273     DOI: 10.1097/SLA.0b013e3181c0e58f

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  18 in total

1.  Computer surveillance of patients at high risk for and with venous thromboembolism.

Authors:  R Scott Evans; James F Lloyd; Valerie T Aston; Scott C Woller; Jacob S Tripp; C Greg Elliott; Scott M Stevens
Journal:  AMIA Annu Symp Proc       Date:  2010-11-13

2.  Procedure-specific venous thromboembolism prophylaxis: a paradigm from colectomy surgery.

Authors:  Peter K Henke; Shipra Arya; Chris Pannucci; Jim Kubus; Samantha Hendren; Michael Engelsbe; Darrell Campbell
Journal:  Surgery       Date:  2012-10       Impact factor: 3.982

3.  Prevention of venous thromboembolism in the critically ill patient.

Authors:  Kira Achaibar; Carl Waldmann
Journal:  J Intensive Care Soc       Date:  2015-07-23

4.  The AVAIL ME study: a multinational survey of VTE risk and prophylaxis.

Authors:  Ali T Taher; Joseph Aoun; Pascale Salameh
Journal:  J Thromb Thrombolysis       Date:  2011-01       Impact factor: 2.300

5.  Association between hospital imaging use and venous thromboembolism events rates based on clinical data.

Authors:  Mila H Ju; Jeanette W Chung; Christine V Kinnier; David J Bentrem; David M Mahvi; Clifford Y Ko; Karl Y Bilimoria
Journal:  Ann Surg       Date:  2014-09       Impact factor: 12.969

6.  Evaluation of venous thromboembolism risk following hospitalization.

Authors:  Sheryl J Herner; Dwight C Paulson; Thomas Delate; Daniel M Witt; Thomas G Vondracek
Journal:  J Thromb Thrombolysis       Date:  2011-07       Impact factor: 2.300

7.  The incidence of deep vein thrombosis detected by routine surveillance ultrasound in neurosurgery patients receiving dual modality prophylaxis.

Authors:  Patricia C Henwood; Thomas M Kennedy; Lynda Thomson; Taki Galanis; George L Tzanis; Geno J Merli; Walter K Kraft
Journal:  J Thromb Thrombolysis       Date:  2011-08       Impact factor: 2.300

8.  Implementation of a Comprehensive Post-Discharge Venous Thromboembolism Prophylaxis Program for Abdominal and Pelvic Surgery Patients.

Authors:  Peter A Najjar; Arin L Madenci; Cheryl K Zogg; Eric B Schneider; Christian A Dankers; Marc T Pimentel; Amrita S Chabria; Joel E Goldberg; Gaurav Sharma; Gregory Piazza; Ronald Bleday; Dennis P Orgill; Allen Kachalia
Journal:  J Am Coll Surg       Date:  2016-09-28       Impact factor: 6.113

9.  Perioperative management of gynecological surgery patients: does fellow involvement improve performance?

Authors:  Holly L Steiner; Catrina C Crisp; Rachel N Pauls
Journal:  Int Urogynecol J       Date:  2012-11-14       Impact factor: 2.894

10.  Prescription of extended-duration thromboprophylaxis after high-risk, abdominopelvic cancer surgery.

Authors:  Jason D Wright; Ling Chen; Soledad Jorge; William M Burke; Ana I Tergas; June Y Hou; Jim C Hu; Alfred I Neugut; Cande V Ananth; Dawn L Hershman
Journal:  Gynecol Oncol       Date:  2016-03-31       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.